Charles River Laboratories | Pasivo Circulante

Current Liabilities Cambio Fecha
Agilent USD 1.62B 14M 2023-12
Align Technology USD 2.07B 56.38M 2023-12
Bio-Rad Laboratories USD 522.8M 35.38M 2023-12
Bruker USD 1.19B 118.7M 2023-12
Cardinal Health USD 38.29B 3.22B 2023-12
Catalent USD 1.04B 498M 2023-12
Charles River Laboratories USD 1.06B 61.27M 2023-12
Cigna USD 47.06B 286M 2023-09
CVS Health USD 79.19B 2.36B 2023-12
Dentsply International USD 1.42B 207M 2023-12
Galapagos EUR 444.04M 31.04M 2023-09
Hologic USD 899M 308.3M 2023-12
Illumina USD 1.57B 88M 2023-12
Incyte USD 1.24B 115.7M 2023-12
IQVIA Holdings USD 6.49B 98M 2023-12
Laboratory Of America USD 3.23B 324.4M 2023-12
Lonza CHF 2.71B 369M 2023-06
McKesson USD 51.15B 2.72B 2023-09
Merck EUR 8.68B 161M 2023-09
Mettler Toledo International USD 1.18B 110.66M 2023-12
Pfizer USD 31.14B 3.51B 2023-09
Revvity USD 1.45B 2.62M 2023-12
United Therapeutics USD 804.4M 60.3M 2023-12
Walgreens Boots Alliance USD 26.12B 1.58B 2023-09
Waters USD 745.03M 64.36M 2023-09
West Pharmaceutical Services USD 533.5M 21.9M 2023-09



Charles River Laboratories Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2024.